Back

Rhelion confirms further PEX010 delivery to Germany’s first psilocybin program

Verifying
  • Rhelion Life Sciences confirmed further delivery of Filament Health’s PEX010.
  • Germany’s first psilocybin compassionate use program is receiving the delivery.
  • The announcement identifies PEX010 as Filament Health’s product.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.